Man Group PLC Outset Medical, Inc. Transaction History

Man Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.67 - $21.7 $520,198 - $769,482	-35,460 Reduced 66.45%	17,900 $285,000
Q2 2022 Aug 15, 2022	BUY	$13.46 - $48.16 $418,417 - $1.5 Million	31,086 Added 139.56%	53,360 $793,000
Q1 2022 May 16, 2022	BUY	$34.22 - $47.24 $239,095 - $330,065	6,987 Added 45.71%	22,274 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$43.29 - $58.77 $80,952 - $109,899	-1,870 Reduced 10.9%	15,287 $704,000
Q3 2021 Nov 15, 2021	BUY	$36.86 - $54.98 $37,081 - $55,309	1,006 Added 6.23%	17,157 $848,000
Q2 2021 Aug 16, 2021	BUY	$41.49 - $59.92 $295,948 - $427,409	7,133 Added 79.1%	16,151 $807,000
Q1 2021 May 17, 2021	BUY	$46.94 - $58.66 $423,304 - $528,995	9,018 New	9,018 $490,000

131

39M

65.1K

91.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $32.6M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.